1. Home
  2. Browse
  3. National Institutes of Health
  4. PAR-28-042

PAR-28-042National Institutes of Health

Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH2/UH3 Clinical Trial Not Allowed)

Deadline
Award ceiling
Not stated
Awards
Not stated
Posted
Nov 3, 2026

Official announcement on Grants.gov · opens the funder's page. Always confirm dates there.

Summary

The purpose of the Notice of Funding Opportunity (NOFO) is to support the analytical and clinical validation of molecular, cellular, and imaging biomarkers and assays for cancer detection, diagnosis, prognosis, monitoring, prediction of response or resistance to treatment, cancer prevention and control, as well as pharmacodynamic markers…

Preparing an application?

On Plus, $39 a month

  • The eligibility check against your profile: career stage, institution type, and the windows that close before the deadline does

Cancel any time. Browsing stays free.

Subjects

More from National Institutes of Health

Open now with at least two weeks to apply, soonest deadline first.

Everything open from National Institutes of Health

Related by subject

Open opportunities sharing the most subjects with this one (Cancer), with at least two weeks to apply.

Everything open tagged Cancer

Hiring in this research area now

All oncology jobs

Source record: https://www.grants.gov/search-results-detail/360946Via Grants.gov. Last checked against the source . Always confirm dates with the funder.